S5N (p.Ser5Asn) variant of MYPN (Myopalladin)
S5N (p.Ser5Asn) in MYPN (Myopalladin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.25 / 1. The record also includes population frequency data and structural context.
S5N (p.Ser5Asn) variant details
- p.Ser5Asn
- NCI-TCGA Cosmic COSV1005
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.246
- REVEL 0.06
- CADD 19.30
- PolyPhen-2 0.00
- SIFT 0.59
- UniProt: Variant assessed as somatic; moderate impact.
- Most common in the Non-Finnish European population (allele frequency 3.6e-06)
- Structural context available